You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Article metrics

Article menu
Position article and guidelines
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

 

Online download statistics by month:

Online download statistics by month: April 2024 to January 2026

AbstractFullPdf
Apr 202415421561758
May 2024774776425
Jun 2024489490175
Jul 2024272274171
Aug 2024247253107
Sep 2024247248244
Oct 2024299302173
Nov 2024332334161
Dec 2024268272127
Jan 2025239240103
Feb 2025444445123
Mar 2025250258143
Apr 2025240240135
May 2025245246120
Jun 202516216370
Jul 2025110
Aug 2025110
Jan 2026210
Total605461053035